Acute sinusitis, exacerbation of chronic bronchitis, pneumonia, complicated and uncomplicated urinary tract infections (including pyelonephritis), skin and soft tissue infections, septicemia/bacteremia, intraabdominal infections.
active substance: levofloxacin 1 film-coated tablet contains levofloxacin hemihydrate, equivalent to levofloxacin 500 mg
excipients: microcrystalline cellulose, crospovidone, povidone, colloidal silicon dioxide, talc, magnesium stearate shell – Opadry 0ZV565038 (sorbic acid, hydroxypropyl cellulose, titanium dioxide (E 171), hypromellose, vanillin, quinoline), yellow aluminum lacorbates (E propylene glycol).
Levoflox Dosage form
Levoflox Pharmacological group
Antibacterial agents of the quinolone group. Fluoroquinolones. Levofloxacin. ATC code J01M A12.
Levoflox is prescribed for the treatment of mild to moderate infections caused by microorganisms sensitive to levofloxacin: acute sinusitis, exacerbation of chronic bronchitis, pneumonia, complicated and uncomplicated urinary tract infections (including pyelonephritis), skin and soft tissue infections, chronic bacterial prostatitis.
Hypersensitivity to levofloxacin or other quinolones, epilepsy, tendon side reactions after prior quinolone administration.
Method of administration and dosage
Levofloxacin tablets are taken 1 or 2 times a day. The dose depends on the type and severity of the infection and the sensitivity of the suspected pathogen. The duration of treatment depends on the course of the disease. It is recommended to continue treatment with the drug for at least 48-72 hours after the normalization of body temperature or the destruction of pathogens confirmed by microbiological tests.
Mode of application
Levoflox tablets should be swallowed without chewing, drinking plenty of liquid. You can take them both with food and at other times.
Levoflox tablets should be taken at least 2:00 before or 2:00 after taking medications that include iron salts, zinc salts, antacids or didanosine containing magnesium or aluminum, and sucralfate, since these drugs can reduce absorption …
Infections and invasions: fungal infections, incl. fungi of the genus Candida, proliferation of other resistant microorganisms.
From the blood and lymphatic system: leukopenia, eosinophilia, neutropenia, agranulocytosis, pancytopenia, hemolytic anemia, thrombocytopenia, which can lead to an increased tendency to hemorrhage or bleeding.
Disorders of the nervous system: headache, dizziness / numbness, drowsiness, tremors, dysgeusia, convulsions, paresthesias, peripheral sensory or sensorimotor neuropathy, decreased sense of touch, parosmia, including anosmia, ageusia, dyskinesia, extrapyramidal disorders and other coordination disorders. hours while walking, fainting, benign intracranial hypertension.
Visual disorders: visual impairment, blurred vision, temporary loss of vision.